Home / Health / Future of Medicine / Sarepta’s gene therapy for Duchenne raises hopes
Genetic Editing Stock Photo

Sarepta’s gene therapy for Duchenne raises hopes

An experimental gene therapy for Duchenne muscular dystrophy, licensed to Sarepta Therapeutics, produced jaw-dropping increases in a crucial muscle protein normally missing in patients with the disease, according to preliminary clinical trial data released Tuesday.

Boston Globe’s Stat

About Boston Globe

Boston Globe

Check Also

Genetic Editing Stock Photo

Advanced Cell Therapy Summit Next Month in Shanghai

Leading doctors and scientists from around the world will gather in Shanghai, China at the …

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.